ANP (Atrial Natriuretic Peptide) Dosage Guide
65/100 confidenceComplete guide to ANP (Atrial Natriuretic Peptide) dosing protocols, administration methods, and safety considerations for research purposes.
NOT Medical Advice
The dosage and calculator information provided is for educational and research purposes only. Peptides are not approved by the FDA for human use. Individual responses vary significantly. Always consult with a qualified healthcare professional before making any decisions related to peptide research or use.
Dosage Overview
Dose Range
1 mcg - 5 mcg
Route
iv
Frequency
3x daily
Detailed Dosage Information
Clinical use: Carperitide (recombinant ANP) used in Japan for acute heart failure at 0.1mcg/kg/min IV infusion.
Administration Method
Intravenous infusion only for clinical applications. Short half-life (~2 minutes) requires continuous administration.
Research Backing
Multiple RCTs/meta-analyses on low-dose ANP for AKI prevention (RR reduction in RRT need); first-in-human MANP studies (1–5 mcg/kg SC safe).
Side Effects to Monitor
Hypotension (dose-limiting), headache, nausea, and potential arrhythmias at high doses.
Safety Considerations & Risks
Significant hypotension risk. Requires careful monitoring. Not widely approved outside Japan.